Your browser does not support the NLM PubReader view.

Go to this page to see a list of supporting browsers.
MedPharmRes
University of Medicine and Pharmacy at Ho Chi Minh City

MedPharmRes

eISSN: 2615-9139

DOI: https://doi.org/10.32895/MPR.25.00005

Article

Lynch Syndrome in Vietnamese Patients with Colorectal Cancer: Prevalence and Clinicopathologic Characteristics from a Single-Center Study

Cong Bang Huynh1, Nien Vinh Lam2, Viet Van Ung3,*
1University Medical Center, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam, 700000
2Department of Biochemistry, Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam, 700000
3Department of Surgery, Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam, 700000
*Corresponding author: Viet Van Ung. E-mail: Viet.uv@umc.edu.vn

© Copyright 2025 MedPharmRes. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Published Online: Jul 29, 2025

Abstract

Background: Lynch syndrome (LS) is the most common hereditary cause of colorectal cancer (CRC), but the prevalence and clinical characteristics of this disorder among Vietnamese patients remain underreported. This study estimated the prevalence and described the clinical characteristics of LS in a hospital-based population in Vietnam.

Methods: A cross-sectional study on prospective data was conducted at the University Medical Center, Ho Chi Minh City (2022–2024), including 190 CRC participants underwent panel genetic testing for LS-associated genes (MLH1, MSH2, MSH6, PMS2, EPCAM).

Results: LS was diagnosed in 12/190 patients (6.3%); the prevalence for MLH1, MSH2, MSH6 mutations was 3.7%. The most frequent mutations were in MSH2 (25%) and PMS2 (33.3%). LS patients were significantly younger (49.7 ± 14.5 vs. 60.3 ± 12.1 years, p = 0.004), with 50% diagnosed before 50-year-old. Right-sided tumours were more common (58.3%). Most LS cases were in stage 3 (50%), and 58.3% had no family history of CRC.

Conclusion: The LS prevalence in Vietnamese CRC patients was higher than expected, particularly for PMS2 mutations. 58.3% of LS patients had no family history, and 50% were aged ≥50 years, suggesting potential false negatives according to traditional screening criteria. Expanding genetic testing to older patients and those without a family history could improve LS detection and management.

Keywords: Lynch syndrome; colorectal cancer; Vietnam; genetic testing